Home » Newsletters » BioWorld Asia

BioWorld Asia

Feb. 17, 1999

View Archived Issues

PowderJect, Ares-Serono Enter $100M Deal For Dry Vaccines

British Biotech's Marimastat Fails In Pivotal Cancer Study

Genetically Modified Milk Could Be Next On Shelves

Biota's Influenza Drug Wins Pair Of Approvals

Genset Reports Highest Quarterly Loss Of Year

European Parliament Calls For Amended GMO Rules

Cerep Revenues Hit Slump After Several Contracts End

EU Backs Biosafety Protocol, Warns Of 'Extreme Positions'

GMO Soya Crops Will Outdo Other Variety, Says Professor

Trinity Biotech's EPS Up 67 Percent For Year

Virax Shares Valued Higher After Patents

Monsanto's GMO Cotton Plan Still Stymied By EU

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 31, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026